Logo image of EPOW

SUNRISE NEW ENERGY CO. LTD-A (EPOW) Stock Fundamental Analysis

NASDAQ:EPOW - Nasdaq - KYG3932F1063 - Common Stock - Currency: USD

0.9  0 (0%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to EPOW. EPOW was compared to 82 industry peers in the Professional Services industry. EPOW may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, EPOW is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

EPOW had negative earnings in the past year.
In the past year EPOW has reported a negative cash flow from operations.
EPOW had negative earnings in 4 of the past 5 years.
EPOW had negative operating cash flow in 4 of the past 5 years.
EPOW Yearly Net Income VS EBIT VS OCF VS FCFEPOW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

EPOW has a worse Return On Assets (-8.23%) than 77.78% of its industry peers.
Industry RankSector Rank
ROA -8.23%
ROE N/A
ROIC N/A
ROA(3y)-16.43%
ROA(5y)-6.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EPOW Yearly ROA, ROE, ROICEPOW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for EPOW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EPOW Yearly Profit, Operating, Gross MarginsEPOW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

0

2. Health

2.1 Basic Checks

EPOW does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EPOW has more shares outstanding
Compared to 5 years ago, EPOW has more shares outstanding
The debt/assets ratio for EPOW is higher compared to a year ago.
EPOW Yearly Shares OutstandingEPOW Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPOW Yearly Total Debt VS Total AssetsEPOW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

EPOW has an Altman-Z score of -0.42. This is a bad value and indicates that EPOW is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.42, EPOW is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.42
ROIC/WACCN/A
WACC7.1%
EPOW Yearly LT Debt VS Equity VS FCFEPOW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

2.3 Liquidity

A Current Ratio of 0.73 indicates that EPOW may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.73, EPOW is doing worse than 86.42% of the companies in the same industry.
EPOW has a Quick Ratio of 0.73. This is a bad value and indicates that EPOW is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EPOW (0.52) is worse than 91.36% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.52
EPOW Yearly Current Assets VS Current LiabilitesEPOW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 52.66% over the past year.
Looking at the last year, EPOW shows a very strong growth in Revenue. The Revenue has grown by 44.28%.
Measured over the past years, EPOW shows a very strong growth in Revenue. The Revenue has been growing by 29.38% on average per year.
EPS 1Y (TTM)52.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.58%
Revenue 1Y (TTM)44.28%
Revenue growth 3Y106.23%
Revenue growth 5Y29.38%
Sales Q2Q%75.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPOW Yearly Revenue VS EstimatesEPOW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EPOW. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EPOW Price Earnings VS Forward Price EarningsEPOW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EPOW Per share dataEPOW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EPOW!.
Industry RankSector Rank
Dividend Yield N/A

SUNRISE NEW ENERGY CO. LTD-A

NASDAQ:EPOW (6/20/2025, 8:00:02 PM)

0.9

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)04-26 2024-04-26
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners8.56%
Ins Owner ChangeN/A
Market Cap24.29M
AnalystsN/A
Price TargetN/A
Short Float %0.1%
Short Ratio0.69
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.37
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS2.41
BVpS-0.38
TBVpS-0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.23%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-16.43%
ROA(5y)-6.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 50.49%
Cap/Sales 3.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.52
Altman-Z -0.42
F-Score5
WACC7.1%
ROIC/WACCN/A
Cap/Depr(3y)773.17%
Cap/Depr(5y)734.51%
Cap/Sales(3y)43.68%
Cap/Sales(5y)52.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.66%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)44.28%
Revenue growth 3Y106.23%
Revenue growth 5Y29.38%
Sales Q2Q%75.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y38.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.51%
OCF growth 3YN/A
OCF growth 5YN/A